TABLE 3.

Percentage (Number) of Patients Reporting at Least 1 Adverse Event, an Inhalation Site Disorder, or a Respiratory System Disorder

HFA−BDP 100–200 μg (n = 183)CFC−BDP+S 200–400 μg (n = 64)P Value
At least 1 adverse event92 (169)91 (58).856
Adverse event on inhalation3 (6)2 (1).480
Respiratory system disorder86 (158)83 (53).715
Acute asthma episode8 (15)11 (7).517
Bronchitis10 (19)0 (0).009
Coughing26 (47)25 (16).921
Increased asthma symptoms43 (79)41 (26).759
Pharyngitis23 (42)34 (22).092
Rhinitis43 (79)47 (30).659
Sinusitis12 (22)14 (9).676
Upper respiratory tract infection45 (82)53 (34).335